COST vs JNJ
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COST is a Hold and JNJ is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
COST’s FA Score shows that 4 FA rating(s) are green whileJNJ’s FA Score has 2 green FA rating(s).
- COST’s FA Score: 4 green, 1 red.
- JNJ’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
COST’s TA Score shows that 5 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s).
- COST’s TA Score: 5 bullish, 3 bearish.
- JNJ’s TA Score: 4 bullish, 6 bearish.
Price Growth
COST (@Discount Stores) experienced а +3.13% price change this week, while JNJ (@Pharmaceuticals: Major) price change was +5.90% for the same time period.
The average weekly price growth across all stocks in the @Discount Stores industry was +4.32%. For the same industry, the average monthly price growth was +9.52%, and the average quarterly price growth was -0.65%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.49%. For the same industry, the average monthly price growth was -6.12%, and the average quarterly price growth was -11.03%.
Reported Earning Dates
COST is expected to report earnings on May 30, 2025.
JNJ is expected to report earnings on Jul 22, 2025.
Industries' Descriptions
@Discount Stores (+4.32% weekly)Companies in the discount stores industry specialize in offering substantial discounts on a vast array of retail products. Some companies in this industry also operate general merchandise warehouse clubs. Products sold at discount stores are typically similar to those of any department store, but the pricing of the goods is generally much lower (and hence the name “discount”). Think Dollar General Corporation, Dollar Tree, Inc. and Five Below, Inc. Many discount stores target low-income households and/or price-sensitive consumers as their potential market. Discount stores’ profitability could hinge on factors like competitive pricing, sufficient locations, healthy revenue per square foot, and effective advertisement. These store operators could have an edge over other retailers during financial crises or recessions, when many consumers could be looking for less expensive alternatives.
@Pharmaceuticals: Major (+3.49% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
| COST | JNJ | COST / JNJ | |
| Capitalization | 441B | 380B | 116% |
| EBITDA | 12.6B | 23.3B | 54% |
| Gain YTD | 8.658 | 9.757 | 89% |
| P/E Ratio | 58.06 | 30.34 | 191% |
| Revenue | 264B | 85.2B | 310% |
| Total Cash | 13.2B | 22.9B | 58% |
| Total Debt | 8.04B | 29.3B | 27% |
COST | JNJ | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 94 | 74 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 97 Overvalued | 18 Undervalued | |
PROFIT vs RISK RATING 1..100 | 4 | 20 | |
SMR RATING 1..100 | 30 | 45 | |
PRICE GROWTH RATING 1..100 | 18 | 52 | |
P/E GROWTH RATING 1..100 | 22 | 57 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
JNJ's Valuation (18) in the Pharmaceuticals Major industry is significantly better than the same rating for COST (97) in the Specialty Stores industry. This means that JNJ’s stock grew significantly faster than COST’s over the last 12 months.
COST's Profit vs Risk Rating (4) in the Specialty Stores industry is in the same range as JNJ (20) in the Pharmaceuticals Major industry. This means that COST’s stock grew similarly to JNJ’s over the last 12 months.
COST's SMR Rating (30) in the Specialty Stores industry is in the same range as JNJ (45) in the Pharmaceuticals Major industry. This means that COST’s stock grew similarly to JNJ’s over the last 12 months.
COST's Price Growth Rating (18) in the Specialty Stores industry is somewhat better than the same rating for JNJ (52) in the Pharmaceuticals Major industry. This means that COST’s stock grew somewhat faster than JNJ’s over the last 12 months.
COST's P/E Growth Rating (22) in the Specialty Stores industry is somewhat better than the same rating for JNJ (57) in the Pharmaceuticals Major industry. This means that COST’s stock grew somewhat faster than JNJ’s over the last 12 months.
| COST | JNJ | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 72% | 3 days ago 44% |
| Stochastic ODDS (%) | 3 days ago 30% | 3 days ago 41% |
| Momentum ODDS (%) | 3 days ago 67% | 3 days ago 52% |
| MACD ODDS (%) | 3 days ago 69% | 3 days ago 46% |
| TrendWeek ODDS (%) | 3 days ago 68% | 3 days ago 42% |
| TrendMonth ODDS (%) | 3 days ago 65% | 3 days ago 42% |
| Advances ODDS (%) | 11 days ago 66% | 3 days ago 40% |
| Declines ODDS (%) | 4 days ago 38% | 12 days ago 42% |
| BollingerBands ODDS (%) | N/A | 3 days ago 59% |
| Aroon ODDS (%) | 3 days ago 46% | 3 days ago 34% |
JNJ and
Correlation & Price change
A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.